The estimated Net Worth of John Mooradian is at least $1.3 Миллион dollars as of 12 September 2019. John Mooradian owns over 9,249 units of Integra Lifesciences Corp stock worth over $335,685 and over the last 12 years John sold IART stock worth over $962,742.
John has made over 3 trades of the Integra Lifesciences Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 9,249 units of IART stock worth $315,576 on 12 September 2019.
The largest trade John's ever made was exercising 9,249 units of Integra Lifesciences Corp stock on 12 September 2019 worth over $315,576. On average, John trades about 996 units every 65 days since 2013. As of 12 September 2019 John still owns at least 19,073 units of Integra Lifesciences Corp stock.
You can see the complete history of John Mooradian stock trades at the bottom of the page.
John's mailing address filed with the SEC is 1100 CAMPUS ROAD, , PRINCETON, NJ, 08540.
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig и George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: